These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37033235)

  • 21. Esterified estrogen therapy in postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes: a two-year study.
    Watts NB; Nolan JC; Brennan JJ; Yang HM;
    Menopause; 2000; 7(6):375-82. PubMed ID: 11127759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].
    Zhao F; Guo XT; Cheng Y; Yang ZF; Liu HP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):734-9. PubMed ID: 24406128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kefir Peptides Prevent Estrogen Deficiency-Induced Bone Loss and Modulate the Structure of the Gut Microbiota in Ovariectomized Mice.
    Tu MY; Han KY; Chang GR; Lai GD; Chang KY; Chen CF; Lai JC; Lai CY; Chen HL; Chen CM
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33182364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of cross-sex hormone therapy on bone mineral density and body composition in transwomen.
    Fighera TM; da Silva E; Lindenau JD; Spritzer PM
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):856-862. PubMed ID: 29630732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
    Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR
    BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal and anthropometric predictors of bone mass in healthy elderly men: major effect of sex hormone binding globulin, parathyroid hormone and body weight.
    Martínez Díaz-Guerra G; Hawkins F; Rapado A; Ruiz Díaz MA; Díaz-Curiel M
    Osteoporos Int; 2001; 12(3):178-84. PubMed ID: 11315235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone mineral density in women with deep infiltrating endometriosis who have undergone early bilateral oophorectomy.
    Gosset A; Escanes C; Pouilles JM; Vidal F; Tanguy Le Gac Y; Plu-Bureau G; Trémollieres FA
    Menopause; 2020 Nov; 28(3):300-306. PubMed ID: 33177413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mineral density and its change in pre-and perimenopausal white women: the Michigan Bone Health Study.
    Sowers M; Crutchfield M; Bandekar R; Randolph JF; Shapiro B; Schork MA; Jannausch M
    J Bone Miner Res; 1998 Jul; 13(7):1134-40. PubMed ID: 9661077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
    Al-Shoumer KA; Nair V
    Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study.
    Yoshimura N; Kasamatsu T; Sakata K; Hashimoto T; Cooper C
    J Bone Miner Metab; 2002; 20(5):303-10. PubMed ID: 12203037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Research on the influence of bilateral oophorectomy on the BMD, body components and sex hormone of women during the perimenopause.
    Wang H; Wang C; Sun L; Zhou S; Wang F
    Pak J Pharm Sci; 2017 Jul; 30(4(Suppl.)):1497-1500. PubMed ID: 29044004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlates of bone mineral density in the postmenopausal estrogen/progestin interventions trial.
    Marcus R; Greendale G; Blunt BA; Bush TL; Sherman S; Sherwin R; Wahner H; Wells B
    J Bone Miner Res; 1994 Sep; 9(9):1467-76. PubMed ID: 7817832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement.
    Gómez JM; Gómez N; Fiter J; Soler J
    Horm Metab Res; 2000 Feb; 32(2):66-70. PubMed ID: 10741688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rates of bone loss in peri- and postmenopausal women: a 4 year, prospective, population-based study.
    Young R; May H; Murphy S; Grey C; Compston JE
    Clin Sci (Lond); 1996 Sep; 91(3):307-12. PubMed ID: 8869413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The non-linear associations of serum follicle-stimulating hormone levels with bone mineral density and the risk of osteoporosis during menopausal transition: an analysis of National Health and Nutrition Examination Survey data.
    Liu Z; Tong H; Su B; Yu M; Chen Y
    Endocrine; 2023 Apr; 80(1):212-220. PubMed ID: 36477941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in bone mineral density in the hip and spine before, during, and after the menopause in elite runners.
    Tomkinson A; Gibson JH; Lunt M; Harries M; Reeve J
    Osteoporos Int; 2003 Jul; 14(6):462-8. PubMed ID: 12730740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial.
    Finkelstein JS; Klibanski A; Arnold AL; Toth TL; Hornstein MD; Neer RM
    JAMA; 1998 Sep 23-30; 280(12):1067-73. PubMed ID: 9757854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone predictors of bone mineral density changes during the menopausal transition.
    Sowers MR; Jannausch M; McConnell D; Little R; Greendale GA; Finkelstein JS; Neer RM; Johnston J; Ettinger B
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1261-7. PubMed ID: 16403818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages.
    Evans SF; Davie MW
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):79-84. PubMed ID: 8706298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.